Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou May 10, 2014 1:58 PM Flag

    Under fire, Pfizer should buy Celldex.

    They would get a slew of drugs and would not have to deal with political fallout in the UK.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They would get a slew of unproven, non-revenue producing drugs. They would not get the tax advantage they're looking for. CLDX will be vanishingly low on their list of priorities.

    • AM would want 8 billion for the company. Majority shareholders would band together and demand twice that.

      The average Joe, who's been pummeled with the up/down whiplashing price would be happy with 6 billion.

      Pfizer would offer three or so . . . if that . . .

    • Besides the Celldex drugs mentioned below, Pfizer would get cdx-011, cdx-110, cdx-1135, cdx-1127 and others.

      CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301in Treating Patients With Stage IIB-IV Melanoma
      This study is currently recruiting participants.
      Verified May 2014 by National Cancer Institute (NCI)
      Sponsor:
      National Cancer Institute (NCI)
      Information provided by (Responsible Party):
      National Cancer Institute (NCI)ClinicalTrials.gov Identifier:
      NCT02129075
      First received: April 30, 2014
      Last updated: May 7, 2014
      Last verified: May 2014

      Sentiment: Strong Buy

 
CLDX
24.74+0.740(+3.08%)May 1 4:00 PMEDT